Epigenome editing in cancer: Advances and challenges for potential therapeutic options

Int Rev Cell Mol Biol. 2024:383:191-230. doi: 10.1016/bs.ircmb.2023.10.001. Epub 2023 Nov 21.

Abstract

Cancers are diseases caused by genetic and non-genetic environmental factors. Epigenetic alterations, some attributed to non-genetic factors, can lead to cancer development. Epigenetic changes can occur in tumor suppressors or oncogenes, or they may contribute to global cell state changes, making cells abnormal. Recent advances in gene editing technology show potential for cancer treatment. Herein, we will discuss our current knowledge of epigenetic alterations occurring in cancer and epigenetic editing technologies that can be applied to developing therapeutic options.

Keywords: Epigenetic alterations; Epigenetic therapeutic options; Epigenome editing.

MeSH terms

  • CRISPR-Cas Systems*
  • DNA Methylation
  • Epigenesis, Genetic
  • Epigenome
  • Gene Editing
  • Humans
  • Neoplasms* / genetics
  • Neoplasms* / pathology
  • Neoplasms* / therapy
  • Oncogenes